Arca Biopharma | ABIO - Debt


Arca Biopharma reported $0 in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Amgen USD 54.6B 17M Dec/2025
Arca Biopharma USD 0 0 Mar/2025
Biogen USD 6.56B 275.1M Mar/2026
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Cytokinetics USD 1.29B 4.48M Mar/2026
Daiichi Sankyo JPY 201.14B 99.81B Sep/2025
Gilead Sciences USD 24.94B 5M Dec/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Grifols EUR 9.23B 626.05M Dec/2024
Laboratory Of America USD 6.53B 3.9M Dec/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Otsuka Holdings JPY 227.98B 16.47B Dec/2025
Pfizer USD 63.73B 231M Mar/2026
United Therapeutics USD 200M 100M Mar/2025